Skip to main content
Clinical Trials/TCTR20131003001
TCTR20131003001
Completed
Phase 3

A randomized controlled trial of electroacupuncture at Body acupoints and Fenglong (ST 40) for regulating serum lipids in dyslipidemic patients in Thailand

Faculty of Medicine, SW0 sites60 target enrollmentOctober 3, 2013

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Dyslipidemia
Sponsor
Faculty of Medicine, SW
Enrollment
60
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 3, 2013
End Date
November 30, 2013
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Faculty of Medicine, SW

Eligibility Criteria

Inclusion Criteria

  • Patients who were diagnosed with dyslipidemia (defined as triglycerides ≥ 150 mg/dL, or total cholesterol (TC) ≥ 200 mg/dL or HDL\-cholesterol (HDL\-C) \< 40 mg/dL (men) or HDL\-C \< 50 mg/dL (women) or LDL\-cholesterol (LDL\-C) \> 130 mg/dL) and were not taking any lipid\-lowering drugs were invited to participate in the study.

Exclusion Criteria

  • Patients who had a history of bleeding disorders or were receiving anticoagulant or anti\-platelet aggregation medications, had epilepsy, uncontrolled hypertension, and active dermatological lesions at the area of acupuncture, as well as pregnant women or those patients whose mental disabilities made their participation in the study difficult were excluded from the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials